Results 71 to 80 of about 4,826 (210)

“Promote locally led initiatives to fight female genital mutilation/cutting (FGM/C)” lessons from anti-FGM/C advocates in rural Kenya

open access: yesReproductive Health, 2020
Background Female Genital Mutilation/cutting (FGM/C) is a tradition rooted in culture and involves the partial or total removal or other injury to the female genital organs for non-medical reasons.
Purity Mwendwa   +4 more
doaj   +1 more source

Comparative analysis of morphology, growth performance and gonadal development between the hybrid crab (Scylla serrata ♀ × S. paramamosian ♂) and S. serrata

open access: yesJournal of the World Aquaculture Society, Volume 57, Issue 2, April 2026.
Abstract Interspecific hybridization, through integrating genetic resources across distinct species, serves as a pivotal strategy for improving yield, stress resistance, and quality in aquacultural species. To evaluate the performance of hybrid crab (Scylla serrata ♀ × S.
Huanyu Zhang   +7 more
wiley   +1 more source

A randomized phase II trial of gemcitabine, nab‐paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer

open access: yesCancer, Volume 132, Issue 6, 15 March 2026.
ABSTRACT Background A randomized phase II screening trial of gemcitabine, nab‐paclitaxel, and cisplatin with a medically supervised ketogenic diet (MSKD) versus usual diet (non‐MSKD) was conducted in patients with treatment‐naive metastatic pancreatic ductal adenocarcinoma (PDAC).
Gayle S. Jameson   +21 more
wiley   +1 more source

A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

open access: yesCancer, Volume 132, Issue 6, 15 March 2026.
ABSTRACT Background Ataxia telangiectasia Rad3‐related (ATR) protein kinase regulates DNA damage response and is essential for tumor cell survival. Preclinically, ATR inhibition can sensitize tumor cells to radiation and chemotherapy. The authors conducted a phase 1 trial of berzosertib, a selective ATR inhibitor, in combination with definitive ...
Aarti Bhatia   +26 more
wiley   +1 more source

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The CATCH experience

open access: yesInternational Journal of Cancer, Volume 158, Issue 6, Page 1675-1689, 15 March 2026.
What's new? CATCH is a prospective precision oncology registry trial that harnesses whole‐genome/exome‐ and RNA‐sequencing to enable actionable biomarker detection in metastatic breast cancer patients of any subtype. The data of the first 412 consecutive patients with completed follow‐up in this real‐world, single‐center patient cohort provide robust ...
Mario Hlevnjak   +31 more
wiley   +1 more source

Woody plant along the elevation gradient of Mt. Meru, Tanzania

open access: green, 2023
Julius Vincent Lasway   +5 more
openalex   +1 more source

Determinants of Migration to Accrual Accounting For the Central and Devolved Governments in Kenya

open access: yesDisclosure
Kenya’s public sector accounting is grappling with ongoing challenges that undermine fiscal transparency and accountability at both the national and county levels. Specifically, there are issues with accounting practices, such as unverified expenditures,
Solomon Ngahu, Cecilia Ndunge Waweru
doaj   +1 more source

Home - About - Disclaimer - Privacy